"Liquid biopsy" for cancer screening
- PMID: 33397684
- DOI: 10.1136/bmj.m4933
"Liquid biopsy" for cancer screening
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: SHB receives funding from Cancer Research UK (CanTest collaborative, [C8640/A23385]) for doctoral research on cancer diagnosis and serves on the executive committee of the Fabian Society, which is a think tank affiliated to the Labour Party. A full statement of interests for SHB is available at https://medicinehealth.leeds.ac.uk/medicine/staff/1211/dr-stephen-bradley. MEB carries out epidemiological and health services research to support earlier diagnosis of cancer but is not involved with research into biomarker tests. He has no other interests to declare. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
Comment in
-
Grail's reply to editorial on "liquid biopsy" for cancer screening.BMJ. 2021 Mar 3;372:n596. doi: 10.1136/bmj.n596. BMJ. 2021. PMID: 33658189 No abstract available.
Similar articles
-
'Liquid biopsy' for cancer promises early detection.Science. 2018 Jan 19;359(6373):259. doi: 10.1126/science.359.6373.259. Science. 2018. PMID: 29348215 No abstract available.
-
From the EACR-ESMO liquid biopsy meeting.Nat Rev Clin Oncol. 2019 Aug;16(8):466. doi: 10.1038/s41571-019-0237-x. Nat Rev Clin Oncol. 2019. PMID: 31150023 No abstract available.
-
[Liquid biopsy: a possible approach for cancer screening].Med Sci (Paris). 2018 Oct;34(10):824-832. doi: 10.1051/medsci/2018208. Epub 2018 Nov 19. Med Sci (Paris). 2018. PMID: 30451677 Review. French.
-
Liquid biopsy: still early days for early detection.Lancet. 2018 Jun 30;391(10140):2593-2594. doi: 10.1016/S0140-6736(18)31476-4. Lancet. 2018. PMID: 30070213 No abstract available.
-
Liquid Biopsies and Critical Illness Insurance: Uncomfortable Bedfellows?J Insur Med. 2019;48(1):48-51. doi: 10.17849/insm-48-1-1-8.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609647 Review.
Cited by
-
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints.EMBO Mol Med. 2024 Nov 14. doi: 10.1038/s44321-024-00169-0. Online ahead of print. EMBO Mol Med. 2024. PMID: 39543322
-
Liquid Biopsy in Adverse Neurodevelopment of Children: Problems and Prospects.Methods Mol Biol. 2023;2695:337-349. doi: 10.1007/978-1-0716-3346-5_23. Methods Mol Biol. 2023. PMID: 37450130 Review.
-
Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma.World J Gastrointest Oncol. 2022 Jan 15;14(1):362-365. doi: 10.4251/wjgo.v14.i1.362. World J Gastrointest Oncol. 2022. PMID: 35116122 Free PMC article.
-
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.Semin Cancer Biol. 2021 Dec;77:99-109. doi: 10.1016/j.semcancer.2021.08.005. Epub 2021 Aug 18. Semin Cancer Biol. 2021. PMID: 34418576 Free PMC article. Review.
-
Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs.Front Vet Sci. 2021 Mar 23;8:664718. doi: 10.3389/fvets.2021.664718. eCollection 2021. Front Vet Sci. 2021. PMID: 33834049 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources